Overview

Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Status:
Suspended
Trial end date:
2022-01-01
Target enrollment:
0
Participant gender:
All
Summary
The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

1. Complains of symptoms suggestive of post-dural puncture headache

2. Has a history of dural puncture (lumbar puncture or accidental dural puncture during
epidural placement) within the previous 7 days

3. Fluent in written and spoken English

Exclusion Criteria:

1. Those with a known history of hypersensitivity to local anesthetics of the amide type
or to other components of GLYDO

2. Those with any congenital or acquired, anatomical deformity of the nostril, which
preclude performing the block

3. Those who refuse to consent to participate in the study

4. Patients who have had a failed epidural blood patch

5. Cognitive Impairment

6. Prisoner